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9. Summary and conclusions 
9.1. Introduction 
This research started with the observation that, in relation to the taxation of health care 
services, in fact two ‘forces’ play a role. The first force is the application of the EU VAT, being 
a general tax on consumption and hence aiming to cover a large number of transactions 
within its scope. The other force is the right to health and, more in particular, access to 
health care. This force aims to keep health care accessible by trying to remove all kinds of 
burdens that could possibly hinder that access. The questions that play a role in this research 
relate to the interaction of these two forces with conflicting aims. As a starting point, I 
assumed that, under current positive EU VAT law, the application of those two forces has as a 
result that imposition of EU VAT on health care transactions hinders access to health care. I 
find support for his hypotheses in the case law on EU health care and in prior studies on the 
application of VAT exemptions and exclusions, in particular in relation to public sector 
activities. The hypothesis used in this research therefore is: the imposition of EU VAT on 
health care transactions hinders access to health care. 
In my view, no extensive studies have been conducted so far on the interaction between the 
application of EU VAT on health care transactions and the application of the standard of 
access to health care. I believe that, at this point in time, a research on this interaction is 
useful and even perhaps indispensable for the improvement of EU VAT law and a more 
efficient levying of VAT that adheres to the current state of health care systems in the EU. 
Furthermore, the outcomes of such a research, in my view, would not only be relevant in 
relation to EU VAT but also for studies on the fiscal sustainability of health care systems in the 
EU.  
The assessment of the hypothesis required, on the one hand, an understanding of the 
application of EU VAT law in relation to health care transactions and, on the other hand, the 
exploration of the principle of access to health care. In order to be able to weigh the two 
forces against each other and draw conclusions on the effects of my findings in relation to 
positive EU VAT law and to make recommendations for improvements to the current system, 
a research framework was required. By means of the two central research questions, 
formulated in section 1.3, I aimed to structure this research in a way that the hypothesis is 
tested and insights are provided on possible improvements to the EU VAT system as regards 
health care transactions. 
9.2. Summary and conclusions  
9.2.1. Conclusions as regards the principle of access to health as a standard 
I established that the principle of access to health care is, in the context of human rights law, 
recognized as one of the interrelated essential elements that have been distinguished in the 
scope of the human right to health. A further breakdown of the human right to health even 
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revealed that accessibility also entails financial access to health care, which could explain the 
possible references to this human right by the CJEU in case law on the application of EU VAT 
on health care transactions. The human right to health is recognized in international human 
rights treaties and other legislative documents. It is included in the International Covenant on 
Economic, Social and Cultural Rights (‘ICESCR’), which is considered the central instrument of 
protection for the right to health. The ICESCR is legally binding on the State Parties to the 
Covenant and they have the obligation to progressive realization and some other obligations 
with immediate effect. The EU, as such, was not a party although all of its Member States are. 
I concluded that the right to health — and hence, also the element concerning the 
accessibility of health care — has to be safeguarded while revising or drafting EU (VAT) 
legislation. I feel confirmed in this view, as the access to health care was explicitly recognized 
in 2006 as one of the overarching values of EU health care systems that has to be taken into 
account while drafting proposals concerning health services by the 25 Health Ministers of the 
EU. So far, I concluded that the access to health care, as part of the human right to health, 
serves as a valid standard for the application of EU VAT law.  
9.2.2. Conclusions as regards EU health care systems in relation to this 
research 
In chapter 2 definitions of health care have been explored. These proved to be very broad. 
Furthermore, as the EU health care systems are organized at the national level, no common 
definition of EU health care is available. Therefore, I explored definitions that are used by 
international organizations that conduct qualitative and quantitative research in the field of 
health care. I assumed that they would apply commonly accepted definitions as their 
research goals require them to make – often quantitative – comparisons of the functioning 
and funding of health care systems between EU Member States. The analysis of definitions 
provided insights into the common denominators of health care systems in the EU. The 
common denominators distinguished – i.e. common understandings of health care supplies 
and health care suppliers – have been used to come to a model EU health care system for the 
purpose of this research. To make sure that the EU model health care system would be 
reliable and able to provide information on the effect of the imposition of VAT on health care 
transactions and ultimately the effect on access to health care, certain requirements have 
been set. Next to the requirements that followed from the analysis of definitions, 
requirements derived from the VAT system were formulated. The requirements led to a 
multi-level and demand-driven model health care system, containing basic, parallel and 
successive transactions. An analysis of the Dutch health care system was carried out to 
ensure that the model has practical value and no essential elements have been overlooked. 
This analysis did not call for any alterations in respect of the model health care system. 
9.2.3. Conclusions on the EU VAT perspective on health care transactions 
So far, I explored the normative content of the right to health and concluded that it is a valid 
standard in relation to the application of EU VAT on health care transactions. In chapter 5, 
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explored the relationship between the principle of access to health care and EU VAT. I 
concluded, like the considerations of the CJEU suggest, that the principle of access to health 
care indeed has to be taken into account for the application of EU VAT on health care 
transactions. 
Subsequently, with the establishment of the model health care system in chapter 2, it was 
established which kind of health care transactions potentially take place within the EU. The 
next step was the assessment of the VAT burden on health care transactions, which was 
undertaken in chapter 6. In that chapter, I concluded that the levying of EU VAT on health 
care transactions, by its nature, increases the cost price of health care transactions. Even if 
health care transactions are not taxed, as a result of the application of VAT exemptions or 
exclusions, the health care supplier incurs a substantial amount of input VAT, which he 
cannot deduct. As a result, the costs of the health care transaction to the health care 
consumer and hence access to health care is affected. The broad scope of both the subject 
(taxable person) and the object (taxable transactions) of the tax include a large part of 
transactions made in the health care sector within the scope of application of EU VAT. 
Furthermore, I have concluded that current mechanisms that are used for VAT relief of those 
transactions are not adequate. The application of VAT exemptions and exceptions form an 
infringement to the general character of the tax. Their application is distortive in many ways. 
This is already a direct consequence of their definition. The harmonized EU VAT system tends 
to subject health care transactions to VAT in a uniform manner, although health care systems 
in the EU are not harmonized. This leads to difficulties as regards the scope of application at 
the national level. Furthermore, this can lead to an unequal treatment of similar health care 
transactions in different Member States. This is a concern, as both the mobility of health care 
consumers and health care suppliers has increased during the last years. Difficulties as 
regards the scope of application also occur on a large scale in national situations. This leads 
to legal uncertainty and increased compliance costs. What makes it even more complicated is 
that the exemption for medical care in the EU VAT Directive is regulated by means of two 
different exemption provisions, i.e. one for intramural and one for extramural care. In order 
to improve legal certainty and reduce compliance costs, I would prefer an exemption for 
health care in a single exemption provision. As such, the legal uncertainty and increased 
compliance costs are factors that hinder the effective levying of the tax. They are a 
complicating factor in relation to the imposition of VAT on health care supplies. I concluded 
that this hindering effect in relation to access to health care cannot be justified by the aims, 
nor by the principles, of EU VAT law. I also concluded that the application of VAT exemptions 
and exclusions may force health care suppliers to make choices that are, from an economic 
point of view, perhaps less efficient. From a cost perspective, for health care suppliers it is in 
general not efficient to outsource services that are subject to VAT. This phenomenon is 
referred to as the bias towards insourcing. A similar effect occurs in cases of cooperation 
between health care suppliers. This also proves to lead to a substantial VAT burden in many 
cases.  
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Even though the CJEU seems to imply that VAT exemptions for health care transactions 
intend to facilitate access to health care, I demonstrated in chapter 6 that, from a conceptual 
point of view, exemptions are by definition distortive and are capable of hindering access to 
health care, in the worst case even with the accumulation of VAT. In conclusion, the levying 
of EU VAT on health care transactions would increase the costs price of health care 
transactions. As a result of the application of VAT exemptions and exclusions, a large number 
of health care transactions are not taxed with VAT. Nevertheless, these transactions are 
burdened to some extent with increased costs, either as a result of non-deductible input VAT 
or as a result if substantial compliance costs. The distortive effects of those mechanisms are 
often not justifiable on grounds of the aims or principles of EU VAT law. 
9.2.4. Conclusions as regards the application of EU VAT in specific types of 
situations 
In order to be able to answer the first research question completely, I aimed to demonstrate 
in which types of situations the application of exemption provisions hinders access to health 
care. In chapter 2, I already identified common types of transactions which typically occur in 
the health care sector.  
It appeared in chapter 7 that the scope of application of health care exemptions differs 
depending on the situation and relationship in which the health care is provided. The scope 
of application in basic situations is different from the scope of application of health care 
exemptions in parallel situations. Furthermore, the scope of application in these two 
situations also differs from the scope of application in situations in which health care is 
supplied as a successive supply (successive situations). Therefore, I made a distinction 
between ‘basic health care supplies’, 'parallel health care supplies' and 'successive health 
care supplies'. In all three situations, I analysed both the application of the exemption 
provision for intramural care (Article 132(1)(b) of the EU VAT Directive), as well as the 
application of the exemption provision for extramural care (Article 132(1)(c) of the EU VAT 
Directive). The assessment of the basic health care supplies confirmed the findings in chapter 
6. In my view, the application of Article 132(1)(c) of the EU VAT Directive results in more legal 
uncertainty for the health care suppliers supplying services in basic situations compared to 
the application of Article 132(1)(b) of the EU VAT Directive. This follows from the way the 
exemption provision is defined. The exemption provision for extramural care in Article 132 
(1)(c) sets requirements as regards the professional qualifications of the providers and 
demands that the health care provided is within the area of expertise of the medical 
profession.  
The hindering effect of VAT exemptions on access to health care in parallel health care 
supplies was analysed by distinguishing parallel one-on-one and parallel two-on-one 
situations. As regards the application of the exemption provision for extramural care, I 
concluded that the ‘closely related test’ that is necessary for the assessment of the 
application of the exemption provision for intramural care is superfluous in parallel one-on-
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one situations. This is because the ‘closely related test’ requires the ancillary transaction to 
also be essential. On the other hand, the scope of application of the ‘closely related test’ 
appears broader. Where composite supplies can only be found in parallel one-on-one 
situations, closely related supplies can be found in parallel two-on-one situations and 
successive situations as well.  
  
